Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-07-30 4:31 pm Sale |
2021-07-26 | 13D | Inozyme Pharma, Inc. INZY |
Novo Holdings A/S | 1,167,706 4.970% |
-801,673 (-40.71%) |
Filing History |
| 2021-05-10 4:05 pm Purchase |
2021-04-29 | 13G | Inozyme Pharma, Inc. INZY |
ADAGE CAPITAL PARTNERS GP LLC | 1,288,672 5.490% |
1,288,672 (New Position) |
Filing History |
| 2021-03-30 4:55 pm Sale |
2021-03-25 | 13D | Inozyme Pharma, Inc. INZY |
Novo Holdings A/S | 1,969,379 8.400% |
-225,000 (-10.25%) |
Filing History |
| 2021-03-04 06:20 am Purchase |
2020-07-28 | 13D | Inozyme Pharma, Inc. INZY |
Sofinnova Venture Partners X L.P. | 2,028,308 8.700% |
2,028,308 (New Position) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Inozyme Pharma, Inc. INZY |
RA Capital Management, L.P. | 2,003,653 8.600% |
2,003,653 (New Position) |
Filing History |
| 2021-02-12 1:30 pm Purchase |
2020-12-31 | 13G | Inozyme Pharma, Inc. INZY |
New Enterprise Associates 15 L.P. | 2,437,689 10.400% |
2,437,689 (New Position) |
Filing History |
| 2021-02-09 5:08 pm Unchanged |
2020-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Pivotal bioVenture Partners Fund I L.P. | 1,591,154 6.800% |
0 (Unchanged) |
Filing History |
| 2021-02-01 4:31 pm Sale |
2021-01-28 | 13D | Inozyme Pharma, Inc. INZY |
Novo Holdings A/S | 2,194,379 9.400% |
-375,000 (-14.59%) |
Filing History |
| 2020-10-05 4:45 pm Unchanged |
2020-09-30 | 13D | Inozyme Pharma, Inc. INZY |
Novo Holdings A/S | 2,569,379 11.000% |
0 (Unchanged) |
Filing History |
| 2020-08-07 5:21 pm Purchase |
2020-07-28 | 13D | Inozyme Pharma, Inc. INZY |
Longitude Capital Partners III LLC | 2,819,379 12.100% |
2,819,379 (New Position) |
Filing History |
| 2020-08-06 10:58 am Purchase |
2020-07-28 | 13G | Inozyme Pharma, Inc. INZY |
Flynn James E | 1,150,299 5.150% |
1,150,299 (New Position) |
Filing History |
| 2020-08-04 08:30 am Purchase |
2020-07-28 | 13D | Inozyme Pharma, Inc. INZY |
Pivotal bioVenture Partners Fund I L.P. | 1,591,154 7.100% |
1,591,154 (New Position) |
Filing History |
| 2020-07-29 4:42 pm Purchase |
2020-07-28 | 13D | Inozyme Pharma, Inc. INZY |
Novo Holdings A/S | 2,569,379 11.500% |
2,569,379 (New Position) |
Filing History |